• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Unique populations among those seeking emergency care for dermatologic problems

byAdam Whittington
May 6, 2014
in Chronic Disease, Dermatology, Emergency
Reading Time: 2 mins read
Discharge diagnoses in the E.R. cannot retrospectively identify non-emergent visits
Share on FacebookShare on Twitter

Image: PD 

1. In the United States, the number of visits to the emergency room (ER) due to skin symptoms is rising. 

2. A patient given a primary dermatologic diagnosis upon discharge from the ER was more likely to be Caucasian or Native American, uninsured, male, and of low socioeconomic status. 

Evidence Rating Level: 2 (Good)

Study Rundown: In the United States, emergency room (ER) visits are becoming more common. Likewise, ER visits due to dermatologic complaints have risen by 2.5 million in the past decade and now comprise 4.2% of all emergency visits. These authors sought to determine the prevalence of particular skin pathologies leading to emergent medical attention and to characterize this demographic of patients. Authors found that patients with a dermatologic primary diagnosis were more likely male, Caucasian or Native American, uninsured, low income, and to visit on the weekend. Identification of this information may lead to further studies about optimizing emergency services for this demographic. A strength of this study was its large sample size. However, only data from California was collected, which may limit the generalization of the results.

Click to read the study in the Journal of American Academy of Dermatology

RELATED REPORTS

Earlier Genetic Testing Predicts Bilateral Mastectomy in Young BRCA Carriers

Uterine-Sparing Mesh Repair Outperforms Hysterectomy for Prolapse

Daraxonrasib showed antitumor activity in previously treated RAS-mutant non–small-cell lung cancer

Relevant reading: Dermatological conditions presenting at the Emergency Department in Siena University Hospital from 2006 to 2011

In-Depth [retrospective cohort]: Records of patients discharged from California ERs from 2005 to 2011 were analyzed, using ICD-9 codes to classify diagnoses. A total of 46,188,747 patient records were screened, yielding 2,078,660 cases with dermatologic primary diagnoses. Of these individuals, multivariate logistic regression was employed to compare demographic data between those with and without primary dermatologic diagnoses. It was found that <18 years (OR 0.83 95% CI 0.83-0.84, P<0.001), >54 years (OR 0.70, 95% CI 0.70-0.71, P<0.001), Black (OR 0.92 95% CI 0.91-0.92, P<0.001), Hispanic (OR 0.88 95% CI 0.88-0.89, P<0.001), and Asian (OR 0.79, 95% CI 0.79-0.80, P<0.001) patients were less likely to be discharged with a dermatologic primary diagnosis. Whereas, male (OR 1.34 95% CI 1.33-1.34, P<0.001), uninsured (OR 1.54, 95% CI 1.54-1.55, P <0.001) and weekend (OR 1.07, 95% CI 1.07-1.08, P <0.001) patients had a higher likelihood of a primary dermatologic diagnosis in the ED.

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

 

Previous Post

Massachusetts health reform linked with fewer all-cause, treatable deaths

Next Post

Women’s Health Initiative results in high-value economic return

RelatedReports

USPSTF recommends chemoprevention for women at high risk for breast cancer
Surgery

Earlier Genetic Testing Predicts Bilateral Mastectomy in Young BRCA Carriers

September 4, 2026
Similar outcomes after supracervical vs. total hysterectomy
Surgery

Uterine-Sparing Mesh Repair Outperforms Hysterectomy for Prolapse

September 4, 2026
Dacomitinib may be effective in EGFR-associated lung cancer
Oncology

Daraxonrasib showed antitumor activity in previously treated RAS-mutant non–small-cell lung cancer

September 4, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Next Post
Conjugated equine estrogens may elevate risk of venous thrombosis

Women’s Health Initiative results in high-value economic return

Classics Series, Landmark Trials in Medicine

The CHARM-Preserved trial: Candesartan in heart failure with preserved ejection fraction [Classics Series]

Repeat bone mineral density testing may not improve prediction of fracture outcomes

Age, bone mineral density may predict fracture after alendronate discontinuation

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Earlier Genetic Testing Predicts Bilateral Mastectomy in Young BRCA Carriers
  • Uterine-Sparing Mesh Repair Outperforms Hysterectomy for Prolapse
  • Daraxonrasib showed antitumor activity in previously treated RAS-mutant non–small-cell lung cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in